The Wall Street Journal has an article focusing on Andrew von Eschenbach, commissioner of the US Food and Drug Administration. Critics have charged that the FDA can't manage regulations of everything it's supposed to be regulating, and now von Eschenbach responds that "the agency needs more money than the Bush administration has proposed, and it requires a revamped organization to better oversee drug safety and other issues," according to the article.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.